Minocycline for Chronic Autoimmune Uveitis
Conditions: Minocycline; Uveitis; Retinal Degeneration Intervention: Drug: minocycline Sponsor: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2022 Category: Research Source Type: clinical trials
Minocycline Treatment for Cystoid Macular Edema
Conditions: Minocycline; Cystoid Macular Edema Intervention: Drug: minocycline Sponsor: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2022 Category: Research Source Type: clinical trials
Minocycline for Chronic Autoimmune Uveitis
Conditions: Minocycline; Uveitis; Retinal Degeneration Intervention: Drug: minocycline Sponsor: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2022 Category: Research Source Type: clinical trials
Minocycline Treatment for Cystoid Macular Edema
Conditions: Minocycline; Cystoid Macular Edema Intervention: Drug: minocycline Sponsor: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2022 Category: Research Source Type: clinical trials
Minocycline for Chronic Autoimmune Uveitis
Conditions: Minocycline; Uveitis; Retinal Degeneration Intervention: Drug: minocycline Sponsor: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2022 Category: Research Source Type: clinical trials
A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN ® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects
Condition: Pharmacokinetics Interventions: Drug: DFD-29 (Minocycline) Fasting; Drug: DFD-29 (Minocycline) Fed; Drug: Solodyn (Minocycline) Fasting Sponsors: Journey Medical Corporation; Dr. Reddy's Laboratories Limited Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2022 Category: Research Source Type: clinical trials
Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke
Condition: Acute Ischemic Stroke Intervention: Drug: Minocyclin Sponsor: State University of New York at Buffalo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 10, 2022 Category: Research Source Type: clinical trials